Evidence that fluoride therapy increases trabecular bone density in a peripheral skeletal site - PubMed (original) (raw)
Evidence that fluoride therapy increases trabecular bone density in a peripheral skeletal site
H Resch et al. J Clin Endocrinol Metab. 1993 Jun.
Abstract
We measured the spinal bone density (SBD) and femoral condyle bone density (FCD) in normal and osteoporotic females (n = 219) both before and during fluoride therapy. SBD and FCD in untreated osteoporotics were significantly lower (P < 0.05) than those in the age-matched controls. SBD and FCD were correlated in the untreated (r = 0.62; P < 0.0001) as well as in the fluoride-treated osteoporotics (r = 0.42; P < 0.0001). SBD and FCD were significantly increased (P < 0.05) in response to fluoride therapy. The average rates of increase in FCD and SBD were similar (1.3 +/- 1.3 vs. 1.24 +/- 1.4 mg/cc.month). We conclude that the osteogenic action of fluoride is not limited to the axial skeleton. An increase in trabecular bone density also occurs at peripheral weight-bearing sites such as the femoral condyle.
Similar articles
- [Evidence of fluoride-induced effects on the calcaneus by measurements of broadband ultrasound attenuation (BUA)].
Resch A, Pietschmann F, Bernecker P, Rand T, Willvonseder R, Resch H. Resch A, et al. Rofo. 1994 Dec;161(6):547-50. doi: 10.1055/s-2008-1032583. Rofo. 1994. PMID: 7803779 German. - Fluoride therapy for osteoporosis promotes a progressive increase in spinal bone density.
Farley SM, Libanati CR, Mariano-Menez MR, Tudtud-Hans LA, Schulz EE, Baylink DJ. Farley SM, et al. J Bone Miner Res. 1990 Mar;5 Suppl 1:S37-42. doi: 10.1002/jbmr.5650051350. J Bone Miner Res. 1990. PMID: 2339634 - Sodium monofluorophosphate increases vertebral bone mineral density in patients with corticosteroid-induced osteoporosis.
Rizzoli R, Chevalley T, Slosman DO, Bonjour JP. Rizzoli R, et al. Osteoporos Int. 1995 Jan;5(1):39-46. doi: 10.1007/BF01623657. Osteoporos Int. 1995. PMID: 7703623 Clinical Trial. - Fluoride therapy for osteoporosis: a review of dose response, duration of treatment, and skeletal sites of action.
Dure-Smith BA, Kraenzlin ME, Farley SM, Libanati CR, Schulz EE, Baylink DJ. Dure-Smith BA, et al. Calcif Tissue Int. 1991;49 Suppl:S64-72. doi: 10.1007/BF02555092. Calcif Tissue Int. 1991. PMID: 1933602 Review. - Fluor in the treatment of osteoporosis. An overview of thirty years clinical research.
Dequeker J, Declerck K. Dequeker J, et al. Schweiz Med Wochenschr. 1993 Nov 27;123(47):2228-34. Schweiz Med Wochenschr. 1993. PMID: 8272793 Review.
Cited by
- Effects of fluoride intake on cortical and trabecular bone microstructure at early adulthood using multi-row detector computed tomography (MDCT).
Saha PK, Oweis RR, Zhang X, Letuchy E, Eichenberger-Gilmore JM, Burns TL, Warren JJ, Janz KF, Torner JC, Snetselaar LG, Levy SM. Saha PK, et al. Bone. 2021 May;146:115882. doi: 10.1016/j.bone.2021.115882. Epub 2021 Feb 10. Bone. 2021. PMID: 33578032 Free PMC article. - Comparing the TiOblast and Osseospeed surfaces. Histomorphometric and histological analysis in humans.
Rocci M, Rocci A, Martignoni M, Albrektsson T, Barlattani A, Gargari M. Rocci M, et al. Oral Implantol (Rome). 2008 Apr;1(1):34-42. Epub 2008 Jun 16. Oral Implantol (Rome). 2008. PMID: 23285334 Free PMC article. - Fluoride for treating postmenopausal osteoporosis.
Haguenauer D, Welch V, Shea B, Tugwell P, Wells G. Haguenauer D, et al. Cochrane Database Syst Rev. 2000;2000(4):CD002825. doi: 10.1002/14651858.CD002825. Cochrane Database Syst Rev. 2000. PMID: 11034769 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical